Study to Evaluate Reactogenicity and Immunogenicity of Revaccination With Adjuvanted Influenza Vaccine in Elderly
Clinical trial NCT00386113 · COMPLETED
Trial details
- NCT number
- NCT00386113
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-10-16
- Primary completion
- 2006-11-14
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.